Literature DB >> 12970250

Prognosis of retrograde dissection from the descending to the ascending aorta.

Shuichiro Kaji1, Takashi Akasaka, Minako Katayama, Atsushi Yamamuro, Kenji Yamabe, Koichi Tamita, Maki Akiyama, Nozomi Watanabe, Kazuo Tanemoto, Shigefumi Morioka, Kiyoshi Yoshida.   

Abstract

BACKGROUND: Natural history of aortic dissection (AD) with intimal tear in the descending or abdominal aorta and retrograde extension into the ascending aorta (retrograde AD) remains unknown. The purpose of this study was to elucidate medium-term prognosis of patients with retrograde AD. METHODS AND
RESULTS: Study population consisted of 109 patients with acute type A AD. There were 27 patients (25%) with retrograde AD and 82 patients (75%) with intimal tear in the ascending aorta (antegrade AD). In antegrade AD patients, 60 patients underwent surgery and 22 patients were treated medically. In retrograde AD patients, 14 patients showed localized crescentic high attenuation area along the ascending aortic wall without enhancement in computed tomography. Transesophageal echocardiography revealed complete thrombosis of false lumen (FL) in the ascending aorta (retrograde thrombosed). The remaining 13 patients showed incomplete or no thrombosis (retrograde nonthrombosed). All retrograde nonthrombosed AD patients underwent surgery except for 1 patient with stroke, whereas all retrograde thrombosed AD patients were treated medically. In-hospital mortality rate of retrograde AD patients was significantly lower than that of antegrade AD patients (15% versus 38%, P=0.027). The survival rates in retrograde AD patients were all 85% at 1, 2, and 5 years, which were significantly higher than those of antegrade AD patients (63%, 62%, and 57%, respectively)(P=0.009).
CONCLUSIONS: Patients with type A retrograde AD have better medium-term prognosis than patients with antegrade AD. Retrograde AD patients with thrombosed FL in the ascending aorta could be treated medically with timed surgical repair.

Entities:  

Mesh:

Year:  2003        PMID: 12970250     DOI: 10.1161/01.cir.0000087424.32901.98

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  7 in total

1.  Editorial on the article entitled "the impact of intimal tear location and partial false lumen thrombosis in acute type b aortic dissection".

Authors:  Suk Jung Choo; Joon Bum Kim
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

2.  Best surgical option for arch extension of type B aortic dissection: the open approach.

Authors:  Joon Bum Kim; Thoralf M Sundt
Journal:  Ann Cardiothorac Surg       Date:  2014-07

3.  Clinics in diagnostic imaging (182). Acute descending aortic dissection with aortic root retrograde extension.

Authors:  John Nathan Gifford; Angeline Choo Choo Poh
Journal:  Singapore Med J       Date:  2017-12       Impact factor: 1.858

4.  Aortic emergencies-diagnosis and treatment: a pictorial review.

Authors:  Esther Voitle; Wolfgang Hofmann; Manfred Cejna
Journal:  Insights Imaging       Date:  2015-02-01

5.  Acute retrograde type A aortic dissection: morphologic analysis and clinical implications.

Authors:  Paul D DiMusto; Brooks L Rademacher; Jennifer L Philip; Shahab A Akhter; Christopher B Goodavish; Nilto C De Oliveira; Paul C Tang
Journal:  J Surg Res       Date:  2017-02-27       Impact factor: 2.192

6.  Two Cases of Endovascular Repair with the Stent Graft for Retrograde Type A Acute Aortic Dissection with Complications.

Authors:  Takahiko Masuda; Masaki Hata; Kazuhiro Yamaya; Tomoyuki Suzuki; Naoya Terao
Journal:  Ann Thorac Cardiovasc Surg       Date:  2018-03-03       Impact factor: 1.520

7.  Is obstructive sleep apnoea associated with hypoxaemia and prolonged ICU stay after type A aortic dissection repair? A retrospective study in Chinese population.

Authors:  Xin Xi; Yu Chen; Wei-Guo Ma; Jiang Xie; Yong-Min Liu; Jun-Ming Zhu; Ming Gong; Guang-Fa Zhu; Li-Zhong Sun
Journal:  BMC Cardiovasc Disord       Date:  2021-09-06       Impact factor: 2.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.